000147213 001__ 147213
000147213 005__ 20240229112643.0
000147213 0247_ $$2doi$$a10.1016/j.radonc.2019.09.004
000147213 0247_ $$2pmid$$apmid:31563409
000147213 0247_ $$2ISSN$$a0167-8140
000147213 0247_ $$2ISSN$$a1879-0887
000147213 0247_ $$2altmetric$$aaltmetric:70354415
000147213 037__ $$aDKFZ-2019-02339
000147213 041__ $$aeng
000147213 082__ $$a610
000147213 1001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b0$$eFirst author$$udkfz
000147213 245__ $$aHow to evaluate agreement between quantitative measurements.
000147213 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2019
000147213 3367_ $$2DRIVER$$aarticle
000147213 3367_ $$2DataCite$$aOutput Types/Journal article
000147213 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1577972993_14110
000147213 3367_ $$2BibTeX$$aARTICLE
000147213 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147213 3367_ $$00$$2EndNote$$aJournal Article
000147213 500__ $$a2019 Dec;141:321-326
000147213 520__ $$aWhen a method comparison study is performed, the aim is to evaluate the agreement of measurements of different methods. We present the Bland-Altman plot with limits of agreement as the correct analysis methodology. We also discuss other scaled and unscaled indices of agreement and commonly used inappropriate approaches.
000147213 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000147213 588__ $$aDataset connected to CrossRef, PubMed,
000147213 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b1$$eLast author$$udkfz
000147213 773__ $$0PERI:(DE-600)1500707-8$$a10.1016/j.radonc.2019.09.004$$gp. S0167814019330774$$p321-326$$tRadiotherapy and oncology$$v141$$x0167-8140$$y2019
000147213 909CO $$ooai:inrepo02.dkfz.de:147213$$pVDB
000147213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000147213 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000147213 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000147213 9141_ $$y2019
000147213 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000147213 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIOTHER ONCOL : 2017
000147213 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147213 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147213 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147213 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000147213 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000147213 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147213 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147213 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147213 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147213 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147213 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000147213 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000147213 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000147213 980__ $$ajournal
000147213 980__ $$aVDB
000147213 980__ $$aI:(DE-He78)C060-20160331
000147213 980__ $$aUNRESTRICTED